![]() ![]() Neil Bell, chair of the prostate cancer guideline working group member, and his team concluded. The task force recommends that the PSA test should not be used to screen for prostate cancer," Dr. "Available evidence does not conclusively show that PSA screening will reduce prostate cancer mortality, but it clearly shows an elevated risk of harm. In Monday’s issue of the Canadian Medical Association Journal, the Canadian Task Force on Preventive Health Care reviewed the latest evidence and international best practice to weigh the benefits and harms of PSA screening with or without digital rectal exams. ![]() Screening aims to find cancer before symptoms appear and reduce the chance of dying from cancer with early treatment. Routine PSA prostate cancer test not recommended.The prognosis for most prostate cancers is good, with a 10-year survival rate of 95 per cent. Prostate cancer is the most commonly diagnosed non-skin cancer in men. In most men with prostate cancer, the tumour grows slowly, and they’re likely to die of another cause before the prostate tumour causes any symptoms. A positive PSA test result often leads to more tests such as a biopsy, which carries risks of bleeding, infection, and urinary incontinence. The main problems are false-positive results and over-diagnosis, the review indicated. ![]() Researchers said over-diagnosis occurs when cancer is detected correctly but would not cause symptoms or death. The prostate-specific antigen, or PSA, test measures inflammation that can be elevated for many reasons other than cancer, such as normal enlargement of the prostate with age or an infection. The blood test mostly commonly used to screen men for prostate cancer should be dropped, because it can result in more harm than good, says a Canadian task force. ![]()
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |